DLC1 induces expression of E-cadherin in prostate cancer cells through Rho pathway and suppresses invasion
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
DLC1 induces expression of E-cadherin in prostate cancer cells through Rho pathway and suppresses invasion
Authors
Keywords
-
Journal
ONCOGENE
Volume 33, Issue 6, Pages 724-733
Publisher
Springer Nature
Online
2013-02-04
DOI
10.1038/onc.2013.7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- DLC1 Interaction with -Catenin Stabilizes Adherens Junctions and Enhances DLC1 Antioncogenic Activity
- (2012) V. Tripathi et al. MOLECULAR AND CELLULAR BIOLOGY
- The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasion
- (2012) K J Jeong et al. ONCOGENE
- Full activity of the deleted in liver cancer 1 (DLC1) tumor suppressor depends on an LD-like motif that binds talin and focal adhesion kinase (FAK)
- (2011) G. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Characterization of the roles of RHOC and RHOA GTPases in invasion, motility, and matrix adhesion in inflammatory and aggressive breast cancers
- (2010) Mei Wu et al. CANCER
- E-cadherin negatively regulates neoplastic growth in non-small cell lung cancer: role of Rho GTPases
- (2010) L Asnaghi et al. ONCOGENE
- Thinking outside the box: Using metastasis suppressors as molecular tools
- (2010) Sophie Thiolloy et al. SEMINARS IN CANCER BIOLOGY
- Luteolin inhibits invasion of prostate cancer PC3 cells through E-cadherin
- (2009) Q. Zhou et al. MOLECULAR CANCER THERAPEUTICS
- Adenovirus-mediated restoration of expression of the tumor suppressor gene DLC1 inhibits the proliferation and tumorigenicity of aggressive, androgen-independent human prostate cancer cell lines: prospects for gene therapy
- (2008) M Guan et al. CANCER GENE THERAPY
- Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via 5-Integrin, which Is a Therapeutic Target
- (2008) K. Sawada et al. CANCER RESEARCH
- Rho GTPases in PC-3 prostate cancer cell morphology, invasion and tumor cell diapedesis
- (2008) Linda Sequeira et al. CLINICAL & EXPERIMENTAL METASTASIS
- Rho GTPases in cancer cell biology
- (2008) Francisco M. Vega et al. FEBS LETTERS
- DLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinoma
- (2008) W. Xue et al. GENES & DEVELOPMENT
- DLC1: a significant GAP in the cancer genome
- (2008) A. Lahoz et al. GENES & DEVELOPMENT
- Deleted in Liver Cancer 1 (DLC1) Negatively Regulates Rho/ROCK/MLC Pathway in Hepatocellular Carcinoma
- (2008) Carmen Chak-Lui Wong et al. PLoS One
- DLC-1 suppresses non-small cell lung cancer growth and invasion by RhoGAP-dependent and independent mechanisms
- (2007) Kevin D. Healy et al. MOLECULAR CARCINOGENESIS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search